| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/28/2011 | US20110097796 Method for freezing and storing cells |
| 04/28/2011 | US20110097795 Desiccated Biologics And Methods Of Preparing The Same |
| 04/28/2011 | US20110097794 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
| 04/28/2011 | US20110097793 Cell separation device, cell separation system and cell separation method |
| 04/28/2011 | US20110097792 Interleukin-12p40 variants with improved stability |
| 04/28/2011 | US20110097785 Method of replicating viruses in suspension cultures of dog kidney cells |
| 04/28/2011 | US20110097778 Chimeric alpha-amylase variants |
| 04/28/2011 | US20110097771 Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility |
| 04/28/2011 | US20110097747 Monoclonal antibody binds antigen associated with human tumors |
| 04/28/2011 | US20110097743 Compositions and methods of detecting tiabs |
| 04/28/2011 | US20110097737 Methods and Compositions for Targeting Proteins of Interest to the Host Cell Envelope |
| 04/28/2011 | US20110097733 Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite |
| 04/28/2011 | US20110097731 Novel mitochondrial dye |
| 04/28/2011 | US20110097726 Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 04/28/2011 | US20110097403 Extracellular matrix compositions for the treatment of cancer |
| 04/28/2011 | US20110097392 Antibody bound synthetic vesicle containing molecules for deliver to central and peripheral nervous system cells |
| 04/28/2011 | US20110097353 Poultry viral materials and methods related thereto |
| 04/28/2011 | US20110097346 Dendritic Cells |
| 04/28/2011 | US20110097342 Binding agents |
| 04/28/2011 | US20110097340 Fully human anti-vegf antibodies and methods of using |
| 04/28/2011 | US20110097339 Compositions monovalent for CD28 binding and methods of use |
| 04/28/2011 | US20110097338 Use of Substances for Sensitization of Tumor Cells to Radiation and/or Chemotherapy |
| 04/28/2011 | US20110097334 Novel Marker Genes for Regulatory T Cells from Human Blood |
| 04/28/2011 | US20110097333 Therapeutic and diagnostic agents |
| 04/28/2011 | US20110097330 Novel Gene Disruptions, Compostitions and Methods Relating Thereto |
| 04/28/2011 | US20110097329 Compositions and methods for treating cancer and modulating stress granule formation |
| 04/28/2011 | US20110097328 Methods and compositions for increasing the activity of inhibitory rna |
| 04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
| 04/28/2011 | US20110097324 Compositions and methods for modulating nicotinic/nmda receptor function |
| 04/28/2011 | US20110097314 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 04/28/2011 | US20110097313 Method for the Identification and Separation of Non-regulatory T-cells from a Mixture of Regulatory T-cells |
| 04/28/2011 | US20110097310 Anti-aging or antioxidant composition containing plant stem cell line derived from cambium of panax ginseng |
| 04/28/2011 | US20110097309 Pharmaceutical Agent for Promoting the Functional Regeneration of Damaged Tissue |
| 04/28/2011 | US20110097308 Stem cells treated by in vitro fucosylation and methods of use |
| 04/28/2011 | US20110097300 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 04/28/2011 | US20110097271 Colon Cancer Associated Transcript 1 (CCAT1) As A Cancer Marker |
| 04/28/2011 | US20110097270 Monoclonal Antibodies That Bind or Neutralize Hepatitis B Virus |
| 04/28/2011 | US20110097262 NOVEL ANTI-cMET ANTIBODY |
| 04/28/2011 | US20110097261 Amigo-2-inhibitors for treating, diagnosing or detecting cancer |
| 04/28/2011 | US20110094194 Novel tomato plants |
| 04/28/2011 | CA2778695A1 Methods and compositions for enhancing polypeptide production |
| 04/28/2011 | CA2778664A1 Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency |
| 04/28/2011 | CA2778359A1 Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof |
| 04/28/2011 | CA2778351A1 Composition for inducing tissue regeneration by activating platelet-rich plasma (prp), and method for manufacturing same |
| 04/28/2011 | CA2778237A1 Method for manufacturing a device for regenerating biological tissues |
| 04/28/2011 | CA2777753A1 Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis |
| 04/28/2011 | CA2776942A1 Cell culture/handling product and method for production and use thereof |
| 04/28/2011 | CA2775924A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/27/2011 | EP2314708A1 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 04/27/2011 | EP2314707A1 Method for the expression of a recombinant protein in a mammalian cell |
| 04/27/2011 | EP2314705A2 Methods for altering the reactivity of plant cell walls |
| 04/27/2011 | EP2314701A2 Recombinant expression vector for animal cell |
| 04/27/2011 | EP2314698A1 Xylanases, nucleic acids encoding them and methods for making and using them |
| 04/27/2011 | EP2314696A1 Therapeutic uses of human Interleukin-B50 antagonist. |
| 04/27/2011 | EP2314695A2 Ligand for receptor activator of NF-kappa B, ligand is member of TNF superfamily |
| 04/27/2011 | EP2314686A1 Cells producing antibody compositions |
| 04/27/2011 | EP2314685A1 Cells producing antibody compositions |
| 04/27/2011 | EP2314682A2 Fluorescent protein |
| 04/27/2011 | EP2314679A1 Construction of expression system for rna polymerase derived from influenza virus, crystallization of the rna polymerase, and screening method for anti-influenza agent |
| 04/27/2011 | EP2314674A1 Cells exhibiting neuronal progenitor cell characteristics |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 04/27/2011 | EP2314672A2 Hybrid bioartificial kidney |
| 04/27/2011 | EP2314671A1 Method for culture of stem cell |
| 04/27/2011 | EP2314670A1 A method for creating cell clusters |
| 04/27/2011 | EP2314628A1 Anti-cd27 antibody |
| 04/27/2011 | EP2314625A1 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 04/27/2011 | EP2314621A1 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/27/2011 | EP2314620A1 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/27/2011 | EP2314612A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314611A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314610A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314322A1 Compositions containing genetically modified lung cancer cells expressing a TGF-beta inhibitor |
| 04/27/2011 | EP2314305A2 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 04/27/2011 | EP2314300A1 Mixed cell populations for tissue repair and separation technique for cell processing |
| 04/27/2011 | EP2313772A1 Isolation and/or identification of stem cells having adipocytic, chondrocytic and pancreatic differentiation potential |
| 04/27/2011 | EP2313510A2 Glutamate decarboxylase (gad) transgenic plants with enhanced nitrogen uptake and utilisation |
| 04/27/2011 | EP2313498A1 Recognition sequences for i-crei-derived meganucleases and uses thereof |
| 04/27/2011 | EP2313496A2 Differentiated anucleated cells and method for preparing the same |
| 04/27/2011 | EP2313495A1 Prokaryotic xylose isomerase for the construction of xylose fermenting yeasts |
| 04/27/2011 | EP2313494A2 Production of pluripotent cells through inhibition of bright/arid3a function |
| 04/27/2011 | EP2313493A1 Dental pulp marrow similar cells (dpmsc) and methods of isolating and using |
| 04/27/2011 | EP2313492A1 Clastogenicity testing |
| 04/27/2011 | EP2313487A2 Organ mimic device with microchannels and methods of use and manufacturing thereof |
| 04/27/2011 | EP2313486A1 System and method for controlling a mammalian cell culture process |
| 04/27/2011 | EP2313433A2 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 04/27/2011 | EP2313431A2 Long-acting interferons and derivatives thereof and methods thereof |
| 04/27/2011 | EP1792985B1 Cell fusion promoter and utilization of the same |
| 04/27/2011 | EP1551977B1 Selective, local activation of members of the tnf ligand family of systemically inactive non-antibody tnf ligand fusion proteins |
| 04/27/2011 | EP1532174B1 Anti-igf-i receptor antibody |
| 04/27/2011 | EP1297163B1 Recombinant constructs and their use in reducing gene expression |
| 04/27/2011 | EP1272633B1 Compositions and methods for dendritic cell-based immunotherapy |
| 04/27/2011 | EP1272617B1 Prostate cell lines and their use |
| 04/27/2011 | EP1105486B1 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
| 04/27/2011 | EP1068311B1 Methods and means for obtaining modified phenotypes |
| 04/27/2011 | EP0972031B1 Procollagen assembly |
| 04/27/2011 | CN1910275B Compositions comprising fetal liver cells and methods useful for HCV infection |
| 04/27/2011 | CN1871356B Retroviral virus vectors for delivery of interfering rna |
| 04/27/2011 | CN1845995B Chimeric antigens for breaking host tolerance to foreign antigens |
| 04/27/2011 | CN1515671B Agrobacterium mediated plant nonselective gene conversion method |
| 04/27/2011 | CN102037132A Methods for enhanced production of bone morphogenetic proteins |